本页面由Tiger Trade Technology Pte. Ltd.提供服务

Janux Therapeutics, Inc.

15.33
-0.3900-2.48%
盘后15.330.00000.00%19:34 EDT
成交量:55.00万
成交额:844.68万
市值:9.33亿
市盈率:-8.36
高:15.87
开:15.81
低:15.24
收:15.72
52周最高:35.34
52周最低:12.12
股本:6,083.17万
流通股本:3,913.33万
量比:0.65
换手率:1.41%
股息:- -
股息率:- -
每股收益(TTM):-1.8336
每股收益(LYR):-1.8336
净资产收益率:-11.72%
总资产收益率:-9.44%
市净率:0.99
市盈率(LYR):-8.36

数据加载中...

2026/06/24

重要事件披露

Form 8-K - Current report
2026/06/12

重要事件披露

Form 8-K - Current report
2026/06/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/12

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/05/06

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/29

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/29

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/28

重要事件披露

Form 8-K - Current report
2026/04/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/26

重要事件披露

Form 8-K - Current report
2026/01/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

重要事件披露

Form 8-K - Current report
2025/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities